Cholesterol-Dependent Cytolysin Permeabilization for Mitochondrial Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing mitochondrial function are often invasive, damaging to cells, and fail to accurately measure mitochondrial activity in its natural environment, lacking the ability to differentiate between cellular and mitochondrial membranes, which hinders the evaluation of mitochondrial metabolism and its role in diseases like encephalomyopathies, diabetes, and cancer.
Innovation Solution
The use of cholesterol-dependent cytolysins, such as perfringolysin O (PFO), for selective permeabilization of cellular membranes allows for the assessment of mitochondrial activity without disrupting mitochondrial membranes, enabling the measurement of substrate uptake and product release, and facilitating the evaluation of mitochondrial function in intact cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If traditional permeabilization agents (detergents) are used to assess mitochondrial function, then cellular membranes can be permeabilized to allow measurement, but mitochondrial membranes are also disrupted causing unwanted release of mitochondrial molecules and loss of cellular environment
Solution Approach 1:
The patent uses cholesterol-dependent cytolysins (CDCs) as an intermediary agent that selectively targets plasma membranes through cholesterol recognition, acting as a mediator that achieves permeabilization without directly affecting mitochondrial membranes. The CDCs form pores in the plasma membrane while leaving mitochondrial membranes intact, thus enabling substrate access while preserving mitochondrial integrity and cellular microenvironment.
Solution Approach 2:
The invention exploits the differential cholesterol distribution between plasma membranes (high cholesterol) and mitochondrial membranes (low cholesterol) to achieve selective permeabilization. By targeting the local quality difference in membrane composition, the CDCs selectively permeabilize only the plasma membrane while preserving the unique properties of mitochondrial membranes, allowing localized action without global disruption.
2Measurement precision
If mitochondria are isolated from cells for assessment, then mitochondrial activity can be measured, but the natural cellular microenvironment is lost reducing accuracy of physiological status assessment
Solution Approach 1:
The patent extracts only the necessary function (plasma membrane permeability) while leaving the rest of the system (mitochondria and cellular microenvironment) intact. By selectively removing the barrier function of the plasma membrane through CDC-mediated pore formation, the method enables measurement of mitochondrial activity in situ without extracting or isolating mitochondria from their natural cellular context, thus preserving the physiological relevance of the measurements.
3Measurement precision
If invasive methods are used to measure mitochondrial function, then direct measurement is possible, but cell damage occurs hindering accurate evaluation
Solution Approach 1:
The CDCs serve as a selective intermediary that mediates between the measurement requirement and cell integrity. By forming pores only in cholesterol-rich plasma membranes and not in mitochondrial membranes, the CDCs enable non-invasive measurement of mitochondrial function through the permeabilized plasma membrane while maintaining mitochondrial integrity and overall cell viability, thus allowing accurate measurement without harmful cell damage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a more accurate and reproducible assessment of mitochondrial function, maintaining the cellular microenvironment and allowing for the evaluation of mitochondrial metabolism and the effects of exogenous agents, aiding in the diagnosis of mitochondrial disorders and understanding their pathophysiology.
Implementation Method 1
cholesterol-dependent cytolysins (CDCs) (e.g., perfringolysin O (PFO)) are used to permeabilize plasma membranes and not internal cellular membranes such as mitochondrial membranes
Data Source
AI summary
The invention provides methods, compositions, devices, and kits relating to the use of cholesterol-dependent cytolysins (e.g., PFOs) for measuring intracellular mitochondrial activity.